Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Background Pulmonary vein isolation (PVI) is an established therapy for symptomatic atrial fibrillation (AF) and the cryoballoon (CB) has become a standard tool for PVI. But the technology is limited in certain ways. The novel multi-electrode balloon catheter promises the advantages of a balloon technology in combination with 3D-mapping and more flexible energy delivery. Purpose There is very limited data available regarding the safety and efficacy of the Heliostar™ RF-balloon. We therefore aimed to assess procedure characteristics, efficacy, and safety in direct comparison with the established CB. Methods All patients undergoing PVI using the Heliostar™ between September 2021 and March 2022 were included in this single center registry. Procedural data and outcome were assessed and compared with data from consecutive patients undergoing initial PVI for paroxysmal AF with the CB from our specifically designed database. Results A total of 251 consecutive patients (63±13 years, 54% male) were included. Of those 28 patients undergoing RF-balloon and 223 patients CB PVI. Baseline parameters did not differ between groups. Acute PVI was achieved in all patients using CB and in 26/28 patients (93%) with the RF-balloon. In 2/28 patients an additional single tip catheter was needed. A mean of 11.2±4.9 RF-applications with 2.8±1.4 applications per vein (LSPV 3.2±2.9, LIPV 2.6±2.5, RSPV 2.8±2.0 and RIPV 1.8±0.8) were necessary to achieve a durable isolation. Using the CB, significantly less applications (5.9±2.2;p=<0.001) were needed. While procedure duration (111±30min. vs. 70min.;p=<0.001) and fluoroscopy time (17.2±6.3min. vs. 11.5±4.8min.;p=<0.001) were longer in the Heliostar™ group, time to isolation was significantly shorter using the RF-balloon: LSPV 23.5±12.3 sec. vs. 54.6±38.3 sec. (p=<0.001); LIPV 18.6±10.4 sec. vs. 61.2±46.5 sec. (p=0.002); RSPV 17.4±10.9 sec. vs. 62.5±53.9 sec. (p=<0.001); RIPV 16.1±9.3 sec. vs. 59.3±35.9 sec. (p=<0.001). One pericardial effusion occurred in the Heliostar™ group due to complicated transseptal access. During CB PVI in 4/223 patients (1.8%) a phrenic nerve palsy was observed, which resolved in all patients within 12-month. After 12-month 80% of patients in the Heliostar™ and 79% of patients in the CB group (p=0.9) were free from atrial arrhythmias. Conclusion The novel multi-electrode RF-balloon has shown to be safe and effective with good long-term results. In comparison with the CB, time to isolation was significantly shorter but procedure durations were longer and fluoroscopy exposition was higher using the first generation Heliostar™ without LassostarNav®. This can be attributed to the learning curve applying a new ablation system and the necessity for separate 3D map preparation. More experience is needed in the future, especially with the new generation Heliostar™ to determine the real benefits.

Effective ablation settings that predict chronic scar after atrial ablation with HELIOSTARTM multi-electrode radiofrequency balloon catheter

Mapping the Transmural Scar and Activation for Patients with Ventricular Arrhythmia

Effect of Postablation Monitoring Strategy on Long-Term Outcome for Catheter Ablation of Persistent Atrial Fibrillation

Three-dimensional High-Resolution Dark-Blood Late Gadolinium Enhancement Imaging for Improved Atrial Scar Evaluation

Comparison of the Mid-Term Outcomes of Robotic Magnetic Navigation-Guided Radiofrequency Ablation versus Cryoballoon Ablation for Persistent Atrial Fibrillation.

Real-time electrophysiological characterization of acute and chronic radiofrequency ablation lesions

Very Long-Term Outcome of Catheter Ablation of Post-Incisional Atrial Tachycardia: Role of Incisional and Non-Incisional Scar

Ablating Persistent Atrial Fibrillation Successfully

Pearls and Pitfalls in Catheter Ablation of Persistent Atrial Fibrillation

Clinical efficacy of radiofrequency ablation guided by high-density mapping on persistent atrial fibrillation

Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges

Electrical Ablation with a Balloon Electrode Array: Chronic Electrophysiologic Response

Clinical research on radiofrequency catheter ablation for treating epicardial accessory pathway

Balloon technologies for pulmonary vein isolation - long-term follow-up and comparison of the novel radiofrequency balloon with the cryoballoon in patients with paroxysmal atrial fibrillation

Point-by-Point Pulsed Field Ablation Using a Multimodality Generator and a Contact Force-Sensing Ablation Catheter: Comparison With Radiofrequency Ablation in a Remapped Chronic Swine Heart

Efficacy of Balloon Expandable Extreme-Low Temperature Ventricular Epicardial Cryoablation: A Preclinical Proof of Concept Evaluation

Head-to-head comparison of pulsed field ablation, very high power-short duration, cryoballoon and conventional radiofrequency ablation by LGE-MRI-based ablation lesion assessment

Effective and Safe Radiofrequency Ablation Setup Based on Contact Force Sensing Technology:An in Vivo ;and Pathological Study

Quality assessment of cardiac magnetic resonance myocardial scar imaging prior to ventricular arrhythmia ablation

Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial

Immediate Electrophysiological Characteristics Following Modified Thoracoscopic Ablation Via Unilateral Approach for Non-Valvular Atrial Fibrillation